Association of tumor cells chemoresistance mechanisms and suboptimal systemic cytotoxic treatment results

Q4 Medicine Libri Oncologici Pub Date : 2019-01-29 DOI:10.20471/lo.2018.46.02-03.11
L. Vazdar, R. Šeparović, Ana Tečić-Vuger, M. Pavlovic, Nikolina Lonjak, C. Krstić
{"title":"Association of tumor cells chemoresistance mechanisms and suboptimal systemic cytotoxic treatment results","authors":"L. Vazdar, R. Šeparović, Ana Tečić-Vuger, M. Pavlovic, Nikolina Lonjak, C. Krstić","doi":"10.20471/lo.2018.46.02-03.11","DOIUrl":null,"url":null,"abstract":"Systemic cytotoxic chemotherapeutic treatment of malignant tumors does not fully meet its goal due to the resistance of present tumor cells to the applied therapy. Chemoresistance is complex and multifactorial, caused by numerous mechanisms that alter drug concentration in the cell, by changes in expression of the epidermal growth factor and by activation of intracellular signaling pathways PI3K / Akt and MAPK. The factor of chemoresistance is also an increased level of antioxidative glutathione and glutathione transferase – S enzyme and the presence of tumor stem cells that signifi cantly improve protection of DNA from damage. Apart from cellular factors, resistance is infl uenced by extracellular hypoxia and acidosis and autophagy. Overcoming the chemoresistance is possible by using nanomechanisms for delivery of drugs to tumor cells, autophagy inhibitors like antimalarials chloroquine and hydroxychloroquine and plant polyphenols. By bett er understanding the mechanisms of chemoresistance and it’s overcoming it can be possible to achieve improvement in antitumor treatment.","PeriodicalId":53700,"journal":{"name":"Libri Oncologici","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Libri Oncologici","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20471/lo.2018.46.02-03.11","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Systemic cytotoxic chemotherapeutic treatment of malignant tumors does not fully meet its goal due to the resistance of present tumor cells to the applied therapy. Chemoresistance is complex and multifactorial, caused by numerous mechanisms that alter drug concentration in the cell, by changes in expression of the epidermal growth factor and by activation of intracellular signaling pathways PI3K / Akt and MAPK. The factor of chemoresistance is also an increased level of antioxidative glutathione and glutathione transferase – S enzyme and the presence of tumor stem cells that signifi cantly improve protection of DNA from damage. Apart from cellular factors, resistance is infl uenced by extracellular hypoxia and acidosis and autophagy. Overcoming the chemoresistance is possible by using nanomechanisms for delivery of drugs to tumor cells, autophagy inhibitors like antimalarials chloroquine and hydroxychloroquine and plant polyphenols. By bett er understanding the mechanisms of chemoresistance and it’s overcoming it can be possible to achieve improvement in antitumor treatment.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肿瘤细胞化学耐药性机制与次优全身细胞毒性治疗结果的相关性
恶性肿瘤的全身细胞毒化疗由于目前肿瘤细胞对所应用的治疗具有耐药性,不能完全达到其目的。化疗耐药是复杂的、多因素的,由多种机制引起,包括细胞内药物浓度的改变、表皮生长因子表达的改变以及细胞内信号通路PI3K / Akt和MAPK的激活。化疗耐药的因素还包括抗氧化谷胱甘肽和谷胱甘肽转移酶- S酶水平的增加以及肿瘤干细胞的存在,这些细胞显著改善了DNA免受损伤的保护。除细胞因素外,细胞外缺氧、酸中毒和自噬也会影响耐药。通过使用纳米机制将药物输送到肿瘤细胞、自噬抑制剂(如抗疟药氯喹和羟氯喹)和植物多酚,可以克服化学耐药性。通过更好地了解化疗耐药的机制并克服它,有可能实现抗肿瘤治疗的改进。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Libri Oncologici
Libri Oncologici Medicine-Oncology
CiteScore
0.30
自引率
0.00%
发文量
9
审稿时长
8 weeks
期刊介绍: - Genitourinary cancer: the potential role of imaging - Hemoglobin level and neoadjuvant chemoradiation in patients with locally advanced cervical carcinoma
期刊最新文献
Results of multicenter testing of PIK3CA somatic mutations in hormone-receptor positive HER2-negative advanced breast cancer Use of nasolabial flap for reconstruction of the floor of the mouth defects Hereditary breast and ovarian cancer – University Hospital of Split experiences Breast cancer radiotherapy - changes in fractionation schemes through decades Latest perspectives on the benefits of neoadjuvant therapy for patients with advanced gastric cancer
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1